LIGAND PHARMACEUTICALS INC
Acquires drug royalties and licenses proprietary technologies to biopharmaceutical partners.
LGND | NDAQ
Overview
Corporate Details
- ISIN(s):
 - N/A
 - LEI:
 - Country:
 - United States of America
 - Address:
 - 3911 SORRENTO VALLEY BLVD, 92121 SAN DIEGO
 - Website:
 - https://www.ligand.com/
 - Sector:
 - Mining and quarrying
 - Industry:
 - Mining of non-ferrous metal ores
 
Description
Ligand Pharmaceuticals is a biopharmaceutical company specializing in healthcare investing and technology licensing. Its core business involves acquiring and managing a large, diverse portfolio of royalty-generating assets by providing capital for the clinical development and commercialization of high-value medicines. The company's royalty streams are derived from partnered programs across numerous therapeutic areas, including oncology, kidney disease, and rare conditions. In parallel, Ligand licenses its proprietary drug development platforms, notably Captisol® and NITRICIL™, to a global network of biopharmaceutical partners. This dual strategy positions Ligand as a key technology and capital partner within the life sciences industry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all LIGAND PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LIGAND PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LIGAND PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||